Loading your page…
HIV Infections
Marketing Authorisation Holder: ViiV Healthcare B.V.
EMA Authorisation: 01/07/2019
INN: dolutegravir;lamivudine
AI Drug & Interaction Analysis
Free account required
Ask Osler about Dovato: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.
